diacerein has been researched along with acetaminophen in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Dougados, M; Hochberg, MC | 1 |
| Rai, J; Sharma, R; Singh, K | 1 |
| Abdelmageed, ME; Elshal, M | 1 |
| Harahsheh, E; Hussein, S; Mohamed Kamel, GA | 1 |
| Jin, L; Li, G; Liang, G; Liang, S; Luo, W; Sun, J; Wang, M; Wang, Y; Yu, T | 1 |
1 review(s) available for diacerein and acetaminophen
| Article | Year |
|---|---|
Pharmacological therapy of osteoarthritis.
Topics: Acetaminophen; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chondroitin Sulfates; Glucosamine; Humans; Meta-Analysis as Topic; Osteoarthritis, Hip; Osteoarthritis, Knee | 2001 |
1 trial(s) available for diacerein and acetaminophen
| Article | Year |
|---|---|
Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Anthraquinones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Capsules; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; India; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Placebos; Prospective Studies; Range of Motion, Articular; Recovery of Function; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2012 |
4 other study(ies) available for diacerein and acetaminophen
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Diacerein counteracts acetaminophen-induced hepatotoxicity in mice via targeting NLRP3/caspase-1/IL-1β and IL-4/MCP-1 signaling pathways.
Topics: Acetaminophen; Animals; Anthraquinones; Caspase 1; Chemical and Drug Induced Liver Injury; Interleukin-4; Liver; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Signal Transduction | 2022 |
Diacerein ameliorates acetaminophen hepatotoxicity in rats via inhibiting HMGB1/TLR4/NF-κB and upregulating PPAR-γ signal.
Topics: Acetaminophen; Animals; Anthraquinones; Antioxidants; Chemical and Drug Induced Liver Injury; COVID-19; HMGB1 Protein; Humans; Liver; Male; NF-kappa B; PPAR gamma; Rats; Toll-Like Receptor 4 | 2022 |
Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis.
Topics: Acetaminophen; Animals; Anthraquinones; Apoptosis; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Liver; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Oxidative Stress; RNA | 2022 |